glp-1 vision loss ema recommendation november 2025 Novo's Ozempic linked to rare cases of serious eye disorder, EU regulator says GLP-1 adoption promises to rewrite

Imatinib Therapy for Patients With Recent-Onset Type 1 Diabetes: A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial

Influencing mental health : The gut-brain axis means that gut health can significantly impact mental health and mood

Realworld insights into incretinbased therapy: Associations between changes in taste perception and appetite regulation in individuals with obesity and overweight: A crosssectional study

Salomon, S

The dose that produces significant fat loss is close to the dose that causes concerning kidney lesions

A 2022 observational study from the American Spine Journal reported that overweight patients who lost more than 10% of their body weight experienced significant reductions in lower back pain intensity and frequency